Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Gastrointestinal Stromal Tumors (Phase 1)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hepatitis, Chronic (Phase 1)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Prolymphocytic (Phase 1)

Leukemia, Prolymphocytic, T-Cell (Phase 1)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 2)

Mesothelioma (Phase 1)

Myelodysplastic Syndromes (Phase 1)

Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Primary Myelofibrosis (Phase 2)

Recurrence (Phase 1)

Salivary Gland Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Waldenstrom Macroglobulinemia (Phase 1)